The Global Duchenne Muscular Dystrophy Drugs Market Size was Worth around USD 4.05 Billion in 2024 and is predicted to Grow to around USD 18.48 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 14.80% from 2025 and 2035. The Market Size for duchenne muscular dystrophy drugs provides opportunities, including improved gene therapy, more R&D spending, increased awareness, advantageous regulations, and growing healthcare facilities. Growth is also fueled by new treatment modalities and growing markets.

The Global Duchenne Muscular Dystrophy Drugs Market Size was Worth around USD 4.05 Billion in 2024 and is predicted to Grow to around USD 18.48 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 14.80% from 2025 and 2035. The Market Size for duchenne muscular dystrophy drugs provides opportunities, including improved gene therapy, more R&D spending, increased awareness, advantageous regulations, and growing healthcare facilities. Growth is also fueled by new treatment modalities and growing markets.